Outset Medical Stock (NASDAQ:OM)
Previous Close
$0.75
52W Range
$0.43 - $6.37
50D Avg
$0.61
200D Avg
$2.33
Market Cap
$38.13M
Avg Vol (3M)
$1.21M
Beta
1.95
Div Yield
-
OM Company Profile
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
OM Performance
Peer Comparison
Ticker | Company |
---|---|
OFIX | Orthofix Medical Inc. |
SGHT | Sight Sciences, Inc. |
LUNG | Pulmonx Corporation |
CLPT | ClearPoint Neuro, Inc. |
NPCE | NeuroPace, Inc. |
NVRO | Nevro Corp. |
KIDS | OrthoPediatrics Corp. |
SIBN | SI-BONE, Inc. |
NARI | Inari Medical, Inc. |
INSP | Inspire Medical Systems, Inc. |
SWAV | ShockWave Medical, Inc. |
CVRX | CVRx, Inc. |
CNMD | CONMED Corporation |